Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Navigator Medicines operate as a biotech company.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.
Complement Therapeutics operates as a preclinical stage company.
AIRNA develops RNA editing technologies to create medicines for various diseases.
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
PACT designs Elegant materials produced in tune with the planet earth.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Forbion Capital Partners has invested in 122 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Forbion Capital Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Dyne Therapeutics received $375.1M in a Post-IPO Equity round. Forbion Capital Partners's total known invested capital is $9.1B.
Forbion Capital Partners's average investment size is $91.4M across its portfolio of 122 companies.
Recent Forbion Capital Partners portfolio additions include Solasta Bio, Navigator Medicines, NeRRe Therapeutics, Dyne Therapeutics, Achilles Therapeutics. These companies were founded in 2020 or later.